Abu Dhabi’s Etihad Airways says core operating losses amounted to $758 million for the first half of the year, driven by a nearly 40% drop in revenue due in part to the impact of the coronavirus pan
Alimera Sciences (ALIM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).

New Strong Buy Stocks For August 5th

03:44pm, Wednesday, 05'th Aug 2020
New Strong Buy Stocks For August 5th
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
MyoKardia reports initiating trial for invasive septal reduction therapy. Aileron completes enrollment in chemotherapeutic agent trial.
Muslims worldwide have marked the Eid al-Adha holiday amid a global pandemic that has impacted nearly every aspect of this year’s celebrations
Alimera Sciences, Inc. (NASDAQ:ALIM) Q2 2020 Earnings Conference Call July 30, 2020, 09:00 AM ET Company Participants Scott Gordon - President, CORE IR Rick Eiswirth - President and CEO Phil Jones - C
UN envoy has two months to secure ceasefire but warns that risks are rising
Image source: The Motley Fool. Alimera Sciences Inc (NASDAQ: ALIM)Q2 2020 Earnings CallJul 30, 2020, 1:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remark

Opinion | A Space Race for the 21st Century

11:11pm, Thursday, 30'th Jul 2020
China aims to land a Mars rover, something the EU hasn’t managed.
The biggest, most sophisticated Mars rover ever built is on its way to the red planet
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) Abbott Laboratories (NYSE: ABT) ABIOMED, Inc. (NASDAQ: ABMD) Adamis Pharmaceuticals Corp (NASDAQ: ADMP) Annexon...
Alimera Sciences (ALIM) delivered earnings and revenue surprises of 76.17% and 336.44%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Recap: Alimera Sciences Q2 Earnings

09:32pm, Wednesday, 29'th Jul 2020
Shares of Alimera Sciences (NASDAQ:ALIM) decreased 1.5% after the company reported Q2 results.Quarterly Results Earnings per share fell 628.57% year over year to ($0.51), which beat the estimate of ($
Second Quarter and Recent Company Highlights: * Consolidated Net Revenue Down 8% Compared to Second Quarter 2019 * International Net Revenue Up 89% Compared to Second Quarter 2019 * Net Loss of $
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE